A B S T R A C T The development of immune deposits on the subepithelial surface of the glomerular capillary wall was studied in isolated rat kidneys perfused at controlled perfusion pressure, pH, temperature, and flow rates with recirculating oxygenated perfusate containing bovine serum albumin (BSA) 
INTRODUCTION
The role of tissue deposition of immune complexes (IC)Q formed in the circulation in the pathogenesis of a variety of clinical and experimental diseases is well documented (1) . Granular deposits of immunoglobulin (Ig) and ,81c-,81a, third component of complement (C3) in renal glomeruli are considered immunopathologic hallmarks of glomerulonephritis induced by IC deposition (2) . Diffuse, finely granular deposits of IgG and C3 along the subepithelial surface ofthe glomerular basement membrane (GBM) are characteristic of membranous nephropathy (MN) , the most common cause of idiopathic nephrotic syndrome in adults, and are generally believed to result from glomerular trapping of soluble ICs formed in the circulation (3, 4) . In rats, immunization with an antigen derived from the luminal brush border of proximal tubular epithelial cells (FxlA) results in a glomerular lesion (Heymann nephritis, autologous immune complex nephropathy, AICN) indistinguishable from MN in man (5, 6) . A similar lesion is induced more rapidly by administration of heterologous antibody to Fx1A (passive Heymann nephritis, PHN) (7, 8) . The concept that subepithelial immune deposits in these models of MN represent ICs derived from the circulation is supported by observations that tubular antigen and antibody to it are present in glomerular deposits and in the circulation in AICN (9) (10) (11) , and that ICs that contain tubular antigen circulate in AICN rats coincident with the development of glomerular immune deposits (12) .
These observations, however, do not document a role for circulating ICs in the formation of subepithelial immune deposits, or exclude alternative explanations for this unique pattern of complex localization. Moreover, several features ofthe AICN model are at variance with conditions in which circulating ICs localize in the subepithelial space as defined in studies of chronic serum sickness in the rabbit (4) . In the latter model subepithelial deposits develop in antigen excess and are usually associated with deposits in the subendothelial and mesangial areas as well (4) . In AICN complex deposits develop in marked antibody excess yet are localized exclusively in the subepithelial space (6, 10, 13, 14) . Antibody excess complexes are generally of high molecular weight and tend to localize in the mesangium and reticuloendothelial system, although small circulating complexes may form if the antigenic component is oligovalent rather than multivalent. However, another possible explanation for these discrepancies is that subepithelial immune deposits in AICN and MN form in situ. Recent evidence that under appropriate conditions normal rat glomeruli may bind antibody to FxlA in a discontinuous pattern and that direct injection of anti-FxlA by syringe into a bloodless rat kidney in vivo results in apparent antibody fixation to the glomerular capillary wall support this hypothesis (15) . However, the localization of antibody deposits reported in these studies was not characteristic of MN (15) .
We have studied the mechanism of formation of subepithelial immune deposits with an isolated perfused rat kidney model because many variables that may influence glomerular transport and localization of macromolecules such as glomerular filtration rate (GFR), perfusion pressure, flow, temperature, pH, and perfusate composition (16, 17) can be carefully controlled and monitored in this system. Preliminary data indicating that a glomerular lesion with the ultrastructural and immunofluorescence (IF) features of MN can be produced in the isolated rat kidney perfused with specific antibody to rat proximal tubular antigen has been presented (18) . In the present report our studies of the development of subepithelial immune deposits in the isolated rat kidney are described in detail. They indicate that a glomerular lesion with IF and electron microscopy (EM) features characteristic of MN can be produced experimentally in the absence of circulating ICs.
METHODS
Preparation ofantibody to FxJA. FxlA was prepared from fresh, saline perfused, Sprague-Dawley rat (Charles River Breeding Laboratories, Inc., Wilmington, Mass.) renal cortices as described by Edgington et al. (19) . Male albino rabbits received four immunizations with 20 mg of Fx1A emulsified in coomplete Freund's adjuvanit (Difco Laboratories, Detroit, Mich.) given at weekly intervals and were bled 5 days after the last immunization. Adult male sheep were immuniized three or four times with 75-100 mg of' Fx1A in complete Freund's adjuvant over a 2-mo period. Serum was collected 2 wk after the last immuniization. All antisera were heat inactivated (56°C, 30 min) and absorbed extensively with pooled, lyophilized whole rat plasma and with rat erythrocytes, leukocytes, anid platelets as previously described (20) . To elimninate reactivity with GBM antigens, aliquots of anitiserunm were f'urther absorbed with purified rat GBMI. GBMI was prepared f'rom rat glomeruli isolated by differential sieving technilues as (lescribed by Spiro (21) and modified by Westberg and Michael (22) and was free of tubular contamination by light microscopy. Isolated glomeruli were washed in distilledl water, resuspended in 1.0 NI NaCl, and disrupted by sonication on a Branson Sonifier, model W-350 (Branson Sonic Power Company, Danbury, Conn.) at an output setting of six for 3 mill in six indlividual 30-s bursts. After washing three times in 1.0 NI NaCl and distilled water, intact GBM was lyophilized before use. Antisera were absorbed three times for 1 h at 370C and overnight at 4°C with 0.3 mg of GBM1/mg IgG. To ensure that this procedure was capable ofadequatelv removing nephrotoxic anti-GBM antibodies if any were present, a potent sheep anti-rat nephrotoxic serunm prepared by immunizing sheep with rat glomiieruli as described elsewhere (23) 52 ,000 rpm at 20°C. Purified IgG antibody was concenitrated to 10 mg/ml wvith a stirred ultrafiltration cell and PM30 Diaflow meembrane (Amiconi Corp. Scientific Sys. Div., Lexington, Mass.) and stored at -70°C. Analysis for purity and specificity was carried out by micro-Ouchterlony and immunoelectrophoresis in 1% agarose (24, 25) . IgG content was measured by radial immunodiffusioni (26) . Antibody reactivity was also tested by indirect IF on cryostat sectionis of normal and AICN rat kidneys (cide itnfra) (20) . Antibody specificity was further documented by repeating studies with anitibody absorbed three times with Fx1A, 6 mg/miig IgG. Normal, unabsorbed sheep or rabbit IgG from nonimiimunized animals isolatedl as described above was used in control stuidies.
I.solated perfused kidtey s. The total number of kidneys perfused in this study and the types of perfusions carried out are listed in Table I . Isolated kidneys were perfused according to the method of Nishiitsutsuji-Uwo et al. (27) and Ross et Male Sprague-Dawley rats, 300-450 g (Charles River Breeding Laboratories, Inc.,) were used if the urinary protein excretion was normal (<5 mg/24 h) before study. Rats were anesthetized with an intraperitoneal injection of pentobarbital (0.5 mg/kg). The right ureter was cannulated with PE 10 tubing, and 200 U of heparin injected i.v. The right renal artery was cannulated via the superior mesenteric artery. While the kidney was perfused with perfusate (vide infra), the kidney and ureter were dissected free, and the cannula tied in place. The kidney, pedicle, and ureter were then removed en bloc, perfused for 5 min to remove serum protein, and mounted in the perfusion cabinet.
After perfusion for an equilibration period of 10-15 min, the perfusate volume was adjusted to 100 ml. The temperature was maintained at 38°C and perfusion pressure was kept at 100 mm Hg by adjustment of resistance in a parallel circuit with a screw valve. The pH was maintained at 7.30-7.40 by automatic titration with 0.1 N NaOH. Perfusate flow through the isolated kidney measured by strain gauge manometry varied from 30 to 45 ml/min. After the equilibration period 1 ,uCi of ["4C]inulin (New England Nuclear, Boston, Mass.) and 30 mg of sheep or rabbit anti-FxlA antibody or control IgG were added to the reservoir. Inulin clearance, sodium reabsorption, water reabsorption, and urine flow were measured at 20-min intervals. Perfusions lasted up to 4 h with recirculating perfusate.
To exclude the possibility that ICs were formed in the recirculating perfusate because of release of renal tubular antigens in venous effluent from the isolated kidney, studies were also carried out with nonrecirculating perfusate. These "single pass" perfusions used up to 2 liters of perfusate that contained 10-30 mg/100 ml of antibody or normal IgG and were carried out for a maximum of 50 min.
At selected time intervals tissue obtained by biopsy immediately before the perfusion ended was prepared for light microscopic, IF, and EM studies as outlined below. To systematically compare the findings in the isolated kidney with the glomerular lesion induced by the same antibody in intact animals in our laboratory, rats with AICN and PHN induced as described below were also studied.
The base-line immunopathologic and ultrastructural features of the isolated perfused rat kidney were studied by light, IF, and EM after perfusion of two to four identically prepared kidneys for 10 min, 30 min, 60 min, 2, 3, and 4 h with no IgG added to the perfusate (Table I) .
Induction of AICN and PHN. AICN was induced in 12 150-200 g male Lewis rats (Charles River Breeding Laboratories, Inc.) by a single rear footpad injection of SpragueDawley FxlA in complete Freund's adjuvant (Difco Laboratories) as previously described (13, 20) . Biopsies of AICN rats 3 and 4 wk after immunization were studied. To define the glomerular lesion induced by anti-FxlA antibody in the intact animals, PHN was induced with 10 mg of the same sheep or rabbit IgG antibody to FxlA described above and administered i.v. to 20 150-200 g male Sprague-Dawley rats. Renal tissue was studied by IF and EM at intervals from 10 min to 5 days after antibody injection.
Tissue processing and IF procedures. Tissue obtained by wedge biopsy of isolated perfused kidneys and open renal biopsies in intact animals was processed for examination by light microscopy, IF, and EM as described in detail elsewhere (20) . Tissue for light microscopy was fixed in formalin and stained with periodic acid-Schiff, hemotoxylin and eosin, and Jones silver methenamine stains (Jones & Lamson Products, Waterbury Farrel Div. of Textron Inc., Springfield, Vt.). Colloidal iron and Alcian blue stains carried out at appropriate pH were done to evaluate glomerular sialoprotein (13) .
Direct and indirect IF procedures were performed with reagents, methods, and controls described elsewhere (20, 23) . All biopsies were stained with monospecific antisera to rat IgG, 8lc-,la (C3), and albumin (13) . Antisera to BSA was prepared in rabbits with bovine fraction V (Miles Laboratories Inc.). The IgG fraction was purified as described above and conjugated with fluorescein isothiocyanate (BioQuest, BBL & Falcon Products, Div. of Becton, Dickinson & Co., Cockeysville, Md.) by a dialysis method (30) . All sections of perfused kidneys were stained for BSA. The IgG fraction of monospecific antisera to sheep and rabbit IgG were obtained commercially (Cappel Laboratories, Inc., Downingtown, Pa.) and conjugated with fluorescein as described above. The characteristics of rabbit antisera to rat FxlA have been previously reported (20) . In addition, aliquots of the sheep antibody to FxlA used for perfusion were also conjugated and used in .'* direct IF. The reactivity of these reagents was similar to that of the rabbit antibody used in previous studies (20) . IF staining for FxlA was always carried out before and after partial elution of unfixed cryostat sections with 2.5 M potassium thiocyanate at 37°C for 120 min (9) .
EM results are based on analysis of 168 sections from 31 perfused kidneys including over 100 sections and electron micrographs from kidneys perfused with normal IgG or antiFxlA (Table I) .
Other procedures. Urine protein excretion in intact animals was measured on 24-h specimens collected in metabolic cages by a sulfosalicyclic method (20) . The BSA content of urine produced by the isolated kidney and the concentrations of sheep and rabbit IgG were measured by radial immunodiffusion (26) .
RESULTS
Characteristics of antibody to rat FxlA (19, 31) . By indirect IF the antibody reacted exclusively with the luminal brush borders of proximal tubular epithelial cells in normal rat kidney at a concentration of 9.8 mg/ml, was reactive to a dilution of 1 x 106, and did not give detectable staining of normal glomeruli or vessels in vitro. Antibody was also reactive with glomerular deposits in partially eluted sections of AICN kidneys that had 4+ glomerular deposits of IgG (9, 13, 20) . Absorption with FxlA abolished reactivity with brush borders and AICN glomerular deposits in vitro. Absorption with GBM had no effect on IF reactivity. Control IgG had no demonstrable reactivity with rat plasma, FxlA, or renal antigens by IF.
AICN rats
The glomerular lesions in AICN rats at 3 and 4 wk were similar to those described previously (13, 20) . At 4 wk all rats had 2-3+ deposits of rat IgG and trace-1+ deposits of rat C3 in a very finely granular pattern in all glomeruli (Fig. LA) . When stained with antisera to FxlA, after partial elution with potassium thiocyanate, FxlA was also demonstrable in early glomerular deposits (13, 19) . EM deposits were first detectable 4 wk after immunization and were localized exclusively along the basilar surface of the epithelial cells and in epithelial slit pores (13, 14) (Fig. 1B) . No mesangial or subendothelial deposits were present. No significant glomerular changes were demonstrable by light microscopy. Staining for glomerular polyanion was not reduced (13) . Urine protein excretion in AICN rats at 3-4 wk averaged 5+3 mg/day (n = 12), and was not significantly different from normal.
Passive Heymann nephritis
The i.v. administration to intact rats of 10 (Fig. 1D ). Deposits were seen only in the subepithelial space and slit pores and were identical in appearance and localization to early deposits in AICN (Fig. 1) . Histologic studies revealed no significant light microscopic changes, no spikes by silver stain, and no alteration in glomerular sialoprotein by histochemical criteria up to 5 days, although urine protein excretion began to increase in antibody injected rats at day 4 (28+12 mg/day, n = 12) and reached 52± 10 mg/day on day 5 Fig. 3 ). Deposits of heterologous IgG were detectable in a granular pattern within 10 min after the addition ofantibody to recirculating perfusions in all the kidneys studied (Fig. 3A, inset) . In addition to the finely grannular deposits on capillary walls cut in cross section, a more homogenous deposition of IgG was apparent on areas on basement membrane cut in tangential section (Fig. 3) . Careful study of multiple sections disclosed a granular pattern to all staining seen on the capillary wall (Fig. 3) . No significant increase in granular staining for IgG was present in the mesangium in antibody-perfused kidneys or controls (Fig. 3) . There was an apparent increase in the quantity of immune deposits with duration of perfusion as judged by intensity of IF staining for IgG. The granularity of deposits became clearer with time as described above Recirculating perfusions carried out for 60 and 120 min with sheep anti-FxlA absorbed with GBM showed a pattern of glomerular immune deposits indistinguishable from that described above (Table I) . Sheep antirat nephrotoxic serum similarly absorbed with GBM showed complete loss of anti-GBM activity as evidenced by reduction in heterologous phase proteinuria from 260±40 to 5± 1 mg/day when doses of0.2 ml ofabsorbed serum were administered to groups of 10 normal rats. Linear staining in the intact animal was reduced by GBM absorption from 4+ to trace-I+. Perfusion with anti-FxlA after absorption with FxlA resulted in no significant glomerular immune deposits after 60 and 120 min of perfusion (Table I) .
Single pass perfusions with sheep anti-FxlA resulted in a pattern of glomerular immune deposits similar to those in the recirculating system but of even greater intensity by IF (Fig. 4A) . As in the recirculating system no glomerular localization of heterologous nonantibody IgG could be demonstrated in controls (Fig.  4B) . No FxlA was demonstrable in glomeruli of kidneys perfused in this way and no tubular brush border staining was detectable (Fig. 4) (Fig. 3C) (13, 41) . Although smaller in size, these deposits in antibody-perfused kidneys were identical in localization and distribution to those seen in AICN rats at 4 wk and in PHN rats 4 days after injection of 10 mg ofthe same antibody (Figs. 1, 3) . No mesangial deposits were seen by EM in antibody-perfused kidneys.
Histologic studies. Histologic abnormalities induced by the perfusion procedure per se were assessed by light microscopy in 19 control kidneys studied after 10 min to 4 h of recirculating perfusion. Glomeruli had no detectable morphologic alterations and glomerular sialoprotein was normal by histochemical staining in all perfused kidneys. Some kidneys showed focal tubular dilatation and mild interstitial edema as described by others (32) . There were no histologic differences between kidneys perfused with no IgG, normal IgG, and anti-FxlA antibody. Silver methenamine stains of antibody perfused kidneys did not show spike formation.
DISCUSSION
These results clearly establish that the immunopathologic and ultrastructural features of the glomerular lesion in AICN and PHN, which are indistinguishable from those of MN in man, can be produced experimentally in the rat kidney by perfusion under controlled conditions with antibody to proximal tubular brush border antigens, and hence must have been initiated by in situ complex formation rather than circulating IC deposition. The specificity of this finding was confirmed by the absence of subepithelial immune deposits in kidneys perfused under similar conditions with equivalent amounts of nonantibody IgG and with antibody absorbed with Fx1A. The possibility that preformed ICs were added to the perfusate with the antibody was excluded by isolation of the 7S fraction of the antibody preparations used by gel filtration and by ultracentrifugal analysis of the final antibody preparations. Moreover, the findings in the nonrecirculating system exclude any possibility that soluble ICs formed in the perfusate contributed to the glomerular deposits produced. Thus, the finely granular, subepithelial immune deposits in this model represent the initiation of complex formation by binding of antibody to antigens apparently localized on the epithelial aspects of the glomerular capillary wall. In view of the failure to demonstrate specific antigen in glomeruli or deposits, however, the possibility that nonimmunologic physical-chemical events may contribute to antibody deposition at this site must also be considered. An in situ process of complex formation has previously been demonstrated in basement membranes ofthyroid, testis, and renal tubules (33) (34) (35) (36) . A similar mechanism has also been postulated to result in glomerular deposits in systemic lupus (37) .
The demonstration that subepithelial complex deposits can develop in situ in the glomerulus does not document a role for this mechanism in mediating AICN or PHN or exclude a role for the deposition of circulating ICs in the pathogenesis of glomerular injury in these models. However, previous studies in support of a role for circulating IC deposition in experimental MN must now be re-evaluated. These include the following observations. Antibody to tubular antigen disappears from the circulation of normal rats more rapidly than nonantibody IgG (38) . Tubular antigen and antibody to it can be identified in the circulation (10, 11, 38) and in glomerular deposits in AICN rats (9, 10) . The development of complex deposits in normal kidneys transplanted into rats injected with antibody to tubular brush border antigen 1-3 days earlier has been interpreted as evidence of persistent circulating ICs in the PHN model (31) . Tubular antigen and IgG in a granular, presumably IC form, are deposited in the glomerular mesangium of AICN rats made proteinuric with aminonucleoside of puromycin (20) . ICs of similar composition have also been demonstrated in the circulation of AICN rats (12 (42, 43) . A role for soluble ICs in the pathogenesis of experimental MN has also been suggested by the observations that IF and EM deposits occur in a subepithelial distribution in some rabbits with chronic serum sickness (4, 44) . In this model complex localization at an epimembranous site occurs only when low molecular weight ICs are formed in persistent antigen excess (4). Complex deposition is almost always present in subendothelial and mesangial areas as well (4) . These findings are in marked contrast to the AICN and PHN models where deposits develop in marked antibody excess (10, 20, 31, 38) but localize only in the subepithelial space (6, 8, 13, 14) . Complex deposition is not altered in PHN by varying antibody levels (45) , a manipulation which should change IC size and localization if the antigen is multivalent, and antigen excess results in an acute reduction rather than an increase in basement membrane deposits (46) . Treatment with antihistamines has also been shown not to alter complex formation in PHN (45) . Moreover, numerous attempts to induce IC nephritis by passive infusion of ICs of appropriate size have failed to demonstrate that pre-formed ICs can be filtered from the circulation and localize in the subepithelial space (15, (47) (48) (49) (50) . Stilmant et al. have provided the only tentative evidence that such a phenomenon can occur (51) . In their studies, mice immunized with ferritin developed circulating, ferritin-containing ICs, identified by ultrastructural rather than immunochemical criteria, which appeared to cross the GBM to localize in the subepithelial space. However, more deposits were localized in subendothelial and mesangial areas (51) . Currently published data thus, do not exclude the possibility that the subepithelial deposits which develop in chronic serum sickness may also represent in situ complex formation which occurs only when the antigenic component ofthe complex is present in free form and therefore able to penetrate the GBM to serve as a fixed antigen. Larger aggregates resulting from intravascular IC formation probably localize exclusively in subendothelial and mesangial areas or outside the kidney.
Potentially antigenic macromolecules of appropriate molecular size and charge, such as cationic ferritin, lysozyme, and heparin-protamine polyelectrolyte complexes, can localize by nonimmunologic (probably charge related) mechanisms on the epithelial surface and in slit pores of a normal glomerulus (52) (53) (54) (55) . The distribution of these electron-dense substances resembles that of immune deposits in early AICN or PHN (8, 13, 14) . IgG can apparently penetrate the glomerular capillary wall to the subepithelial space when blood flow is reduced (56) . GBM penetration by IgG under conditions of normal flow may resemble that of ferritin if antibody is present in subgroups with sufficiently cationic isoelectric points (52) . The selective concentration of the anionic ultrastructural tracer molecules, catalase and ferritin, with isoelectric points of 5.7 and 4.6, respectively, in subepithelial deposits in AICN suggests that these deposits are cationic relative to normal GBM (57) . Thus, in situ formation of complexes in a discontinuous pattern on the subepithelial surface of the GBM is consistent with known mechanisms of glomerular transport and distribution of macromolecules.
With regard to the probable glomerular localization of the antigen involved in the AICN and PHN models, our studies are consistent with the hypothesis that it is a constituent of the capillary wall that is immunologically cross reactive with Fx1A. Electron dense deposits in our studies were identified in the subepithelial space in a distribution identical to that in early AICN and PHN. Deposits were not seen at other sites within the capillary wall as reported by Van cryostat sections, others have reported glomerular staining in vitro with similar reagents after pretreatment of glomeruli with neuraminidase and acid buffers (15) . Additional support for the presence of an antigen in the rat glomerulus which can induce a membranous lesion is provided by the studies of Shibata et al. who produced a lesion very similar to AICN by immunizing rats with a highly purified fraction of pronase-digested GBM (58) .
Our results do not clarify the mechanism by which subepithelial immune deposits increase glomerular permeability in the intact animal. The absence of a measurable increase in protein excretion in kidneys perfused with antibody compared to controls is consistent with observations in the intact animal in which comparable amounts of subepithelial immune deposits do not produce proteinuria (13, 20) . Some of the protein excreted by the isolated perfused kidney noted by us and others (27) may be nonglomerular in origin (59) .
In contrast to other studies (15) the electrolyte and protein content of perfusate, perfusion pressure, temperature, and pH in the system used in our experiments all approximated in vivo conditions. The parameters of kidney structure and function measured were not altered during perfusion with antibody and were similar to those reported by other workers in control kidneys (27) (28) (29) . GFR of perfused kidneys was about 50% of that measured in vivo. The low GFR, also found by others, has been attributed to elevated proximal intratubular hydrostatic pressure, uneven distribution of perfusion, mechanical occlusion of glomerular capillaries, and abnormal leakiness of distal nephrons (60) . None of these factors appeared to influence the development of glomerular immune deposits in antibody perfused kidneys since GFR was the same in controls. The possibility that ICs formed because of release of tubular brush border antigen into perfusate was excluded in our studies by demonstrating that similar deposits developed in nonrecirculating perfusions when renal venous effluent was discarded. The increase in renal plasma flow by a factor of 6-10 in isolated kidneys over values in vivo may explain why more deposits are present in the isolated kidney at 2 h than in the antibody injected whole animal (1, 61) .
Our findings demonstrate that in experimental MN the granular pattern of complex deposition believed to be indicative of nephritis mediated by glomerular trapping of circulating ICs, may instead represent antibody binding to antigens present or previously localized in the glomerular capillary wall. If a similar mechanism is operative in vivo, AICN may be more analogous to experimental auto-immune glomerulonephritis or nephrotoxic nephritis induced by anti-GBM antibody than to the chronic serum sickness model with which it is commonly compared (4). The possibility is supported by other studies of the determinants of subepithelial complex localization in this model (45, 46 ). An in situ mechanism of complex formation in MN could have considerable therapeutic significance since the factors known to influence soluble IC localization are different from those affecting antibody binding to fixed tissue antigens (62) .
